Ranft, Andreas
Richter, Günther H. S.
Diaz-Martin, Juan
Jabar, Susanne
Jens, Marvin
Kerkhoff, Maximilian
Blanquer-Maceiras, Maite
Noguera, Rosa
Piro, Inken
Steiger, Katja
Burdach, Stefan
Parra, Alessandro
Picci, Piero
Gambarotti, Marco
Hartmann, Wolfgang
Scotlandi, Katia
de Alava, Enrique
Dirksen, Uta
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 29 October 2025
Accepted: 28 February 2026
First Online: 7 April 2026
Declarations
:
: The authors declare no competing interests.
: The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript is in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations. The EE 99 trial was approved by the leading ethics committee of Ärztekammer Nordrhein Westfalen on Mar. 03, 1999 (Ref. vdl/Vo). The EWING 2008 trial was conducted under the sponsorship of the Westfalian Wilhelms University Muenster, Germany, and approved by the leading ethics committee of Ärztekammer Nordrhein Westfalen on Dec. 16, 2008 (Ref. No. 2008-391-f-A), and by the legal authority, the Paul-Ehrlich Institute (PEI), on Mar. 19, 2009 (Ref. No. 736-01). Informed consent was obtained from all patients included in the analyses. For minor participants a consent from a parent and/or legal guardian for study participation was obtained.